Elli Kruithof

3.5k total citations
41 papers, 2.6k citations indexed

About

Elli Kruithof is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Elli Kruithof has authored 41 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Rheumatology, 9 papers in Hematology and 7 papers in Immunology. Recurrent topics in Elli Kruithof's work include Rheumatoid Arthritis Research and Therapies (30 papers), Spondyloarthritis Studies and Treatments (28 papers) and Systemic Lupus Erythematosus Research (13 papers). Elli Kruithof is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (30 papers), Spondyloarthritis Studies and Treatments (28 papers) and Systemic Lupus Erythematosus Research (13 papers). Elli Kruithof collaborates with scholars based in Belgium, Germany and Netherlands. Elli Kruithof's co-authors include Filip De Keyser, Eric Veys, Dominique Baeten, Filip Van den Bosch, Leen De Rycke, Herman Mielants, Bernard Vandooren, Nancy Van Damme, Johannes Roth and Pieter Demetter and has published in prestigious journals such as Annals of the Rheumatic Diseases, The Journal of Pathology and Drugs.

In The Last Decade

Elli Kruithof

39 papers receiving 2.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Elli Kruithof 2.1k 1.1k 874 312 201 41 2.6k
Leen De Rycke 1.3k 0.6× 681 0.6× 430 0.5× 263 0.8× 79 0.4× 30 1.6k
Antonio R. Cabral 1.0k 0.5× 624 0.5× 484 0.6× 235 0.8× 226 1.1× 53 1.6k
P A Ory 2.8k 1.3× 2.1k 1.8× 1.4k 1.6× 643 2.1× 224 1.1× 21 3.9k
Paolo Durigutto 658 0.3× 715 0.6× 421 0.5× 248 0.8× 125 0.6× 31 1.6k
Pojen Chen 651 0.3× 978 0.9× 287 0.3× 462 1.5× 154 0.8× 14 1.7k
K B Elkon 809 0.4× 771 0.7× 282 0.3× 231 0.7× 106 0.5× 19 1.5k
Mark C. Totoritis 1.2k 0.6× 872 0.8× 430 0.5× 155 0.5× 101 0.5× 15 2.2k
J Arvieux 1.2k 0.5× 433 0.4× 730 0.8× 173 0.6× 226 1.1× 55 1.8k
Roger Aitchison 754 0.4× 366 0.3× 393 0.4× 464 1.5× 76 0.4× 20 1.4k
Kotaro Otomo 752 0.4× 429 0.4× 254 0.3× 125 0.4× 129 0.6× 38 1.2k

Countries citing papers authored by Elli Kruithof

Since Specialization
Citations

This map shows the geographic impact of Elli Kruithof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elli Kruithof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elli Kruithof more than expected).

Fields of papers citing papers by Elli Kruithof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elli Kruithof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elli Kruithof. The network helps show where Elli Kruithof may publish in the future.

Co-authorship network of co-authors of Elli Kruithof

This figure shows the co-authorship network connecting the top 25 collaborators of Elli Kruithof. A scholar is included among the top collaborators of Elli Kruithof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elli Kruithof. Elli Kruithof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cantaert, Tineke, L De Rycke, Bernard Vandooren, et al.. (2006). Anti-tumour necrosis factor alpha-induced apoptosis contributes to the induction of autoantibodies but not the downregulation of synovial inflammatory infiltration in spondyloarthritis. Annals of the Rheumatic Diseases. 65. 182–182. 1 indexed citations
2.
Rycke, Leen De, Elli Kruithof, Bernard Vandooren, Paul P. Tak, & Dominique Baeten. (2006). Pathogenesis of spondyloarthritis: Insights from synovial membrane studies. Current Rheumatology Reports. 8(4). 275–282. 9 indexed citations
3.
Kruithof, Elli, Leen De Rycke, Bernard Vandooren, et al.. (2006). Identification of synovial biomarkers of response to experimental treatment in early‐phase clinical trials in spondylarthritis. Arthritis & Rheumatism. 54(6). 1795–1804. 52 indexed citations
4.
Rycke, Leen De, Bernard Vandooren, Elli Kruithof, et al.. (2005). Increased systemic and local expression of toll-like receptor 2 and 4 in spondyloarthropathy is downmodulated by tumour necrosis factor alpha blockade. Ghent University Academic Bibliography (Ghent University). 4 indexed citations
5.
Rycke, Leen De, Dominique Baeten, Elli Kruithof, et al.. (2005). IgM anti-dsDNA autoantibodies are the main antinuclear reactivity induced by infliximab but not etanercept treatment in vivo: Biological and clinical implications. Ghent University Academic Bibliography (Ghent University). 3 indexed citations
6.
Rycke, Leen De, Tineke Cantaert, Elli Kruithof, et al.. (2005). Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase are pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
7.
Bosch, Filip Van den, Elli Kruithof, Ilse Hoffman, et al.. (2005). Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years. Ghent University Academic Bibliography (Ghent University). 52(9). 635. 1 indexed citations
8.
Kruithof, Elli, Leen De Rycke, Filip De Keyser, et al.. (2005). Identification of synovial biomarkers of response to treatment in spondyloarthropathy. Ghent University Academic Bibliography (Ghent University). 52(9). 633. 1 indexed citations
9.
Houbiers, J. G. A., Elli Kruithof, Bernard Vandooren, et al.. (2005). Impact of natural changes in disease activity on synovial histopathology in rheumatoid arthritis. Annals of the Rheumatic Diseases. 64. 436–436. 2 indexed citations
10.
Kruithof, Elli, Leen De Rycke, Filip Van den Bosch, et al.. (2005). Short and long term synovial immunumodulation by etanercept in spondyloarthropathy. Annals of the Rheumatic Diseases. 64. 82–83. 1 indexed citations
11.
Kruithof, Elli, Dominique Baeten, Leen De Rycke, et al.. (2005). Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Research & Therapy. 7(3). R569–80. 196 indexed citations
12.
Rycke, Leen De, Dominique Baeten, Dirk Foell, et al.. (2005). Differential expression and response to anti‐TNFα treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis. The Journal of Pathology. 206(1). 17–27. 104 indexed citations
13.
Kruithof, Elli, et al.. (2004). Case Number 29: Ochronosis: synovial histopathological characteristics. Annals of the Rheumatic Diseases. 63(2). 130–130. 9 indexed citations
14.
Baeten, Dominique, Elli Kruithof, Leen De Rycke, et al.. (2004). Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: A prospective study in 154 consecutive patients. Arthritis & Rheumatism. 50(9). 2931–2941. 70 indexed citations
15.
Rycke, Leen De, Isabelle Peene, Ilse Hoffman, et al.. (2003). Rheumatoid factor and anti-citrullinated peptide antibodies in rheumatoid arthritis: Diagnostic value and association with radiological progression. Ghent University Academic Bibliography (Ghent University). 48(9). 675. 1 indexed citations
16.
Keyser, Filip De, Dominique Baeten, Filip Van den Bosch, et al.. (2003). Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety, and biological immunomodulation. Rheumatic Disease Clinics of North America. 29(3). 463–479. 15 indexed citations
17.
Rycke, Leen De, Elli Kruithof, Nancy Van Damme, et al.. (2003). Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy. Arthritis & Rheumatism. 48(4). 1015–1023. 159 indexed citations
18.
Kruithof, Elli, et al.. (2002). Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up. Annals of the Rheumatic Diseases. 61(3). 207–212. 109 indexed citations
19.
Bosch, Filip Van den, Elli Kruithof, Dominique Baeten, et al.. (2002). Randomized double‐blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy. Arthritis & Rheumatism. 46(3). 755–765. 277 indexed citations
20.
Kruithof, Elli, Dirk Elewaut, Jean Naeyaert, et al.. (1999). Polyarteritis Nodosa Mimicking Polymyalgia Rheumatica. Clinical Rheumatology. 18(3). 257–260. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026